Sarepta Therapeutics (SRPT) Tumbles on Downgrade

Sarepta Therapeutics Inc SRPT shares fell 11.7% to $12.61. RBC Capital downgraded Sarepta Therapeutics from outperform to sector perform and lowered the price target from $62.00 to $15.00. Share volume was 4.1 million compared to an all-day average of 1.9 million